Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers

Radiotherapy and Oncology

Volumn 96, Issue 3, 2010, Pages 351-355

  Haie Meder, Christine ^a   Mazeron, Renaud ^a   Magné, Nicolas ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Brachytherapy; External irradiation; Gynaecological cancers; PET CT

Indexed keywords

CHOLINE C 11; CISPLATIN; FLUORODEOXYGLUCOSE;

ADVANCED CANCER; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; EARLY CANCER; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TREATMENT PLANNING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 77956181972     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.07.010     Document Type: Review

References (43)

1. G. Lucignani FDG-PET in gynaecological cancers: recent observations Eur J Nucl Med Mol Imaging 35 2008 2133 2139
2. A.M. Maffione, M. Piva, and C.S. Tsamita Positron-emission tomography in gynaecological malignancies Arch Gynecol Obstet 280 2009 521 528
3. N. Magné, C. Chargari, and L. Vicenzi New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET Cancer Treat Rev 34 2008 671 681
4. FIGO Committee on Gynecologic Oncology Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynecol Obstet 105 2009 103 104
5. M. Öllers, G. Osmans, and A. van Baardwijk The integration of PET-CT scans from different hospitals into radiotherapy treatment planning Radiother Oncol 91 2009 85 94
6. Aerts HJWL, Lambin P, De Ruysscher D. FDG for dose painting: A rational choice. Radiother Oncol 2010; doi:10.1016/j.radonc.2010.05.001.
7. R. Poetter Image-guided brachytherapy sets benchmarks in advanced radiotherapy Radiother Oncol 91 2009 141 146
8. T.Z. Wong, E.L. Jones, and R.E. Coleman Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer Mol Imaging Biol 6 2004 55 62
9. A. Loft, A.K. Berthelsen, and H. Roed The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study Gynecol Oncol 106 2007 29 34
10. J. Scheidler, H. Hricak, K.K. Yu, L. Subak, and M.R. Segal Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis JAMA 278 1997 1096 1101
11. M.F. Bellin, C. Roy, and K. Kinkel Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - initial clinical experience Radiology 207 1998 799 808
12. J.W. Roh, S.S. Seo, and S. Lee Role of positron emission tomography in pre-treatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study Eur J Cancer 41 2005 2086 2092
13. M.J. Reinhardt, C. Ehritt-Braun, and D. Vogelgesang Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET Radiology 218 2001 776 782
14. H.H. Chou, T.C. Chang, and T.C. Yen Low value of [18F]-fluoro-2-deoxy-d- glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy J Clin Oncol 24 2006 123 128
15. S. Sironi, A. Buda, and M. Picchio Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT Radiology 238 2006 272 279
16. J.D. Wright, F. Dehdashti, and T.J. Herzog Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-d-glucose- positron emission tomography Cancer 104 2005 2484 2491
17. Y. Sugawara, A. Eisbruch, and S. Kosuda Evaluation of FDG PET in patients with cervical cancer J Nucl Med 40 1999 1125 1131
18. P.G. Rose, L.P. Adler, and M. Rodriguez Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J Clin Oncol 17 1999 41 45
19. W.C. Lin, Y.C. Hung, L.S. Yeh, C.H. Kao, R.F. Yen, and Y.Y. Shen Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings Gynecol Oncol 89 2003 73 76
20. Y. Yildirim, S. Sehirali, and M.E. Avci Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings Gynecol Oncol 108 2008 154 159
21. 18F] fluorodeoxyglucose positron emission tomography scans in the para-aortic area J Clin Oncol 26 2008 2558 2561
22. K. Narayan, R.J. Hicks, and T. Jobling A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment Int J Gynecol Cancer 11 2001 263 271
23. 18FDG PET imaging in the management of cervical cancer Gynecol Oncol 87 2002 90 97
24. E.A. Kidd, B.A. Siegel, F. Dehdashti, J.S. Rader, D.G. Mutch, M.A. Powell, and P.W. Grigsby Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis J Clin Oncol 28 2010 2108 2113
25. P.W. Grigsby, A.K. Singh, B.A. Siegel, F. Dehdashti, J. Rader, and I. Zoberi Lymph node control in cervical cancer Int J Radiat Oncol Biol Phys 59 2004 706 712
26. J. Esthappan, S. Mutic, and R.S. Malyapa Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes Int J Radiat Oncol Biol Phys 58 2004 1289 1297
27. C.J.A. Haasbek, A.L.J. Uitterhoeve, and J. Van der Velden Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery Radiother Oncol 89 2008 197 204
28. J. Green, J. Kirwan, and J. Tierney Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 3 2005 CD002225
29. P.W. Grigsby, D.G. Mutch, and J. Rader Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET Int J Radiat Oncol Biol Phys 61 2005 444 449
30. C. Chargari, N. Magné, and I. Dumas Physics contribution and clinical outcome with 3D MRI-based pulsed dose-rate intracavitary brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 74 2009 133 139
31. R. Pötter, J. Dimopoulos, and P. Georg Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155
32. J.C.A. Dimopoulos, V. De Vos, and D. Berger Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations Radiother Oncol 91 2009 166 172
33. R.S. Malyapa, S. Mutic, and D.A. Low Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer Int J Radiat Oncol Biol Phys 54 2002 1140 1146
34. L.L. Lin, S. Mutic, and D.A. Low Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET Int J Radiat Oncol Biol Phys 67 2007 91 96
35. L.L. Lin, Z. Yang, S. Mutic, T.R. Miller, and P.W. Grigsby FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer Int J Radiat Oncol Biol Phys 65 2006 177 181
36. T. Torizuka, T. Kanno, and M. Futatsubashi Imaging of gynaecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET J Nucl Med 44 2003 1051 1056
37. F. Dehdashti, P.W. Grigsby, J.S. Lewis, R. Laforest, B.A. Siegel, and M.J. Welch Assessing tumor hypoxia in cervical cancer by PET with Cu-labeled diacetyl-bis(N4-methylthioemicarbazone) J Nucl Med 49 2008 201 205
38. J.S. Lewis, R. Laforest, F. Dehdashti, P.W. Grigsby, M.J. Welch, and B.A. Siegel An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix J Nucl Med 49 2008 1177 1182
39. R. Suzuki, E. Miyagi, and B. Takahashi Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer Int J Gynecol Cancer 17 2007 890 896
40. J.Y. Park, E.N. Kim, and D.Y. Kim Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer Gynecol Oncol 108 2008 486 492
41. K. Kitajima, K. Murakami, and E. Yamasaki Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer Am J Roentgenol 190 2008 1652 1658
42. K. Kitajima, K. Murakami, E. Yamasaki, Y. Kaji, and K. Sugimura Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer Eur Radiol 19 2009 1529 1536
43. H.H. Chung, W.J. Kang, and J.W. Kim The clinical impact of [(18)F] FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings Eur J Nucl Med Mol Imaging 35 2008 1081 1088